December 16, 2020
In re Xyrem (Sodium Oxybate) Antitrust Litigation
Case Number:
3:20-md-02966
See also:
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Salahi PC
- Williams & Connolly
- Hagens Berman
- Wilson Sonsini
- Motley Rice
- Spiro Harrison
- Ahdoot & Wolfson
- FBT Gibbons
- Goodwin Procter
- Paul Hastings
- Kirkland & Ellis
- Barnes & Thornburg
- Zelle LLP
- Faegre Drinker
- Girard Sharp
- White & Case
- Berger Montague
- Boies Schiller
- Holland & Knight
- Cooley LLP
- Benesch
- Husch Blackwell
- Weil Gotshal
- Keker Van
- Bibiyan Law Group
- Gibson Dunn
- Winston & Strawn
- O'Melveny & Myers
- Schneider Wallace
- Troutman
- Joseph Saveri Law Firm
- Scott&Scott
- Spector Roseman
- DiCello Levitt
- Wexler Boley
- Feldman Shepherd
- Rawlings & Associates PLLC
- Lowey Dannenberg
- Steven Williams Law
- Radice Law Firm
- Skaggs Faucette
- Fine Kaplan
- Labaton Keller
Companies
- Hikma Pharmaceuticals PLC
- Aetna Inc.
- Humana Inc.
- Ranbaxy
- Blue Cross Blue Shield Association
- Norac Pharma
- Veranova LP
- Endo International PLC
- Express Scripts Holding Co.
- Amneal Pharmaceuticals Inc.
- Health Care Service Corp.
- Lupin Ltd.
- Molina Healthcare Inc.
- Government Employees Health Association Inc.
- Jazz Pharmaceuticals Inc.
- Par Pharmaceutical Cos. Inc.
- United Food & Commercial Workers International Union
- West-Ward Pharmaceutical Corp.
- Florida Blue
- Mallinckrodt PLC
- Wockhardt USA LLC
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 08, 2025
Hikma Cuts $50M Deal To End Antitrust Claims In Xyrem MDL
A certified class of Xyrem buyers in 36 states have asked a California federal judge to preliminarily approve Hikma Pharmaceuticals PLC's $50 million deal to resolve antitrust claims accusing Hikma of colluding with rival Jazz Pharmaceuticals to block generic rivals from competing with Jazz's narcolepsy drug.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login